Identifying Barriers to Therapeutic Adherence in Type 2-Diabetes: A Complex and Multidimensional Clinical Issue

Author:

Siddiqui Mujtaba Hasan1,Akhtar Khan Iqbal2,Moyeen Fauzia3,Chaudhary Khawar Abbas4

Affiliation:

1. Department of Medicine, Akhtar Saeed Medical & Dental College, Lahore, Pakistan

2. Independent Scholar, Lahore, Pakistan

3. Consultant Diabetologoist, Diabetes Wellness Centre, Lahore, Pakistan

4. Department of Medicine, Continental Medical College, Lahore, Pakistan

Abstract

The problem of therapeutic non-adherence is a serious issue adversely affecting the adequate control and management of Type2 Diabetes (T2D).This unwelcoming situation has been studied well on various spots on the globe, with diverse results. The present study, aimed at identifying the barriers to therapeutic adherence, was conducted on a set of proven cases of T2D, managed by primary healthcare providers. The adherence rate to medication alone was 42% while to medication plus lifestyle recommendations 27%. Whereas sub-optimal health literacy, complexity of prescription and socioeconomic aspects were the main determinants, lapse on the part of healthcare system cannot be underscored. The present qualitative study was a preliminary investigation on a small sample .The magnitude of the problem necessitates that a large scale multi-centre in-depth quantitative study in 5 dimensions (recommended by WHO): socio-economic factors, health care team and system related factors, condition related factors , therapy related factors and patient related factors, be done on priority basis. This would pave the way for planning a well-designed intervention programme.

Publisher

Asploro Open Access Publications

Reference35 articles.

1. Kardas P, Lewek P, Matyjaszczyk M, “Determinants of patient adherence: a review of systematic reviews”. Front Pharmacol, vol.4, no.91: 1-28, 2013.

2. ADA, “Diagnosis and Classification of Diabetes mellitus-American Diabetes Association”. Diabetic Care, vol.33, no.suppl 1: s62-s69, 2010.

3. WHO, “Adherence to long term therapies:Evidence for Action”. World Health Organization, Geneva: 2003.

4. WHO, “Global Report on Diabetes”. World Health Organization, Geneva: 2016.

5. Meo SA, Zia I, Bukhari IA, et al., “Type 2 Diabetes mellitus in Pakistan:Current prevalence and future forecast”. J Pak Med Assoc, vol.66, no.12: 1637-42, 2016.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3